31st May, 1-2nd June 2023, Eigtveds Pakhus, Copenhagen, Denmark
The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2023 will offer researchers a fresh forum to discuss this important topic in detail.
MVADS 2023 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.
Scientific Advisory Panel
Conference Chairman: Dennis Christensen (CRODA Denmark, Frederikssund, Denmark)
Gabriel Pedersen (Statens Serum Institut, Copenhagen, Denmark)
Martin Bachmann (Inselspital, Bern, Switzerland / University of Oxford, Oxford, UK)
Derek O’Hagan (GSK Vaccine Research, Cambridge, Massachusetts, USA)
Stefan Jungbluth (European Vaccine Initiative (EVI), Heidelberg, Germany)
Ken Ishi (IMS/University of Tokyo, Tokyo, Japan)
Edward Lavelle (Trinity College Dublin, Dublin, Ireland)
Arnaud Didier-Laurent (University of Geneva, Geneva, Switzerland)
Zoltan Beck (Pfizer Inc., Pearl River, New York, USA)
Emanuele Montomoli (VisMederi Holdings/University of Siena, Siena, Italy)
Conference Scope
Scientific Sessions:
- Mechanistic Interpretations
- Delivery
- Formulation & Design
- Modern Vaccines & Adjuvants
- Safety
- Regulation
- Future Developments